Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-20-051891)

Filing Details

Accession Number:
0001209191-20-051891
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-24 16:21:08
Reporting Period:
2020-09-22
Accepted Time:
2020-09-24 16:21:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662524 Akcea Therapeutics Inc. AKCA Pharmaceutical Preparations (2834) 472608175
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1791857 Kyle Jenne C/O Akcea Therapeutics, Inc.
22 Boston Wharf Road, 9Th Floor
Boston MA 02210		 Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-09-22 720 $18.12 52,012 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on September 19, 2019.